AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a ...

No increase in risk for breast cancer seen for BRCA carriers following predominantly surgical menopause. HealthDay News — Use ...

Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer ...

Longevity medicine is becoming more mainstream. While benefits exists, an expert physician wants patients to remain cautious of information they read or view online.

Here's your Beyond the Gates weekly recap for the episodes that aired January 26-30, 2026!

EastEnders star Kara Tointon opened up about the importance of testing for the genetic risk of breast cancer and her ...

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy found that ...

Here's what went down Monday, January 26, 2026 on Beyond the Gates when Tomás realized his verbal agreement with Bill might ...

Fans will see the entire cancer process play out, according to the series' head writer.

Women with certain genetic mutations are at extremely high risk of ovarian cancer. Now, some researchers are trying a new ...